SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 230 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $197,595 | -51.1% | 223,019 | -13.3% | 0.00% | – |
| Q3 2022 | $404,000 | +29.1% | 257,319 | +65.1% | 0.00% | – |
| Q2 2022 | $313,000 | -19.5% | 155,819 | -6.6% | 0.00% | – |
| Q1 2022 | $389,000 | -53.5% | 166,825 | -7.2% | 0.00% | -100.0% |
| Q4 2021 | $836,000 | -27.8% | 179,757 | +18.5% | 0.00% | 0.0% |
| Q3 2021 | $1,158,000 | +6.2% | 151,757 | +34.9% | 0.00% | 0.0% |
| Q2 2021 | $1,090,000 | +52.9% | 112,457 | +30.4% | 0.00% | 0.0% |
| Q1 2021 | $713,000 | -4.7% | 86,271 | -21.3% | 0.00% | 0.0% |
| Q4 2020 | $748,000 | -43.1% | 109,635 | -6.9% | 0.00% | -50.0% |
| Q3 2020 | $1,314,000 | -9.8% | 117,820 | -49.2% | 0.00% | 0.0% |
| Q2 2020 | $1,456,000 | +6833.3% | 231,829 | +1960.7% | 0.00% | – |
| Q1 2020 | $21,000 | -75.6% | 11,250 | -29.7% | 0.00% | – |
| Q1 2016 | $86,000 | – | 16,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Oaktree Fund Advisors, LLC | 66,000 | $503,000 | 48.93% |
| SABBY MANAGEMENT, LLC | 1,698,107 | $12,957,000 | 1.75% |
| EMFO, LLC | 233,008 | $1,778,000 | 1.57% |
| swisspartners Ltd. | 110,000 | $839,000 | 0.65% |
| HERITAGE WEALTH MANAGEMENT, LLC | 150,000 | $1,145,000 | 0.41% |
| Donald L. Hagan, LLC | 42,929 | $328,000 | 0.19% |
| COLLECTIVE FAMILY OFFICE LLC | 44,203 | $337,000 | 0.14% |
| Spectrum Wealth Advisory Group, LLC | 18,093 | $138,000 | 0.14% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 100,000 | $763,000 | 0.13% |
| Cormorant Asset Management, LP | 400,000 | $3,052,000 | 0.12% |